The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: Ductal epithelial cell targeting with multistage progression to carcinoma

Oncogene

Volumn 19, Issue 8, 2000, Pages 1020-1027

  Green, Jeffrey E ^a   Shibata, Masa Aki ^a,e   Yoshidome, Katsuhide ^a   Liu, Min Ling ^a   Jorcyk, Cheryl ^b   Anver, Miriam R ^c   Wigginton, Jon ^d   Wiltrout, Robert ^d   Shibata, Eiko ^a   Kaczmarczyk, Stanislaw ^a   Wang, Weili ^a   Liu, Zi Yao ^a   Calvo, Alfonso ^a   Couldrey, Christine ^a  

^a Building 41   (United States)

^b BOISE STATE UNIVERSITY   (United States)

^c SAIC FREDERICK INC   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

C3(1); DCIS; Mammary cancer; Prostate cancer; Rat prostate steroid binding protein; SV40 T antigen; Transgenic mice; Tumor progression

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; CYTOKINE; ESTROGEN RECEPTOR ALPHA; STEROID BINDING PROTEIN; VIRUS T ANTIGEN;

APOPTOSIS; BREAST CANCER; BREAST DUCT; BREAST EPITHELIUM; CANCER INFILTRATION; CARCINOMA IN SITU; CELL CYCLE; CHEMOPROPHYLAXIS; CHROMOSOME 6; CONTROLLED STUDY; DNA FLANKING REGION; GENE TARGETING; HETEROZYGOSITY LOSS; HISTOLOGY; LUNG METASTASIS; NONHUMAN; ONCOGENE RAS; PREGNANCY; PRIORITY JOURNAL; PROSTATE; REVIEW; SIMIAN VIRUS 40; TRANSGENIC MOUSE; VIRUS CARCINOGENESIS;

ANIMALIA; MUS MUSCULUS; RNA VIRUSES; RODENTIA; SIMIAE; SIMIAN VIRUS; SIMIAN VIRUS 40;

EID: 0034696246     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203280     Document Type: Review

References (39)

1. Allison J, Zhang YL and Parker MG. (1989). Mol. Cell. Biol., 5, 2254-2257.
2. Amundadottir LT, Merlino G and Dickson RB. (1996). Breast Cancer Res. Trent., 39, 119-135.
3. Carbone M, Fisher S, Powers A, Pass HI and Rizzo P. (1999). J. Cell. Physiol., 180, 167-172.
4. Cardiff RD, Anver MR, Gusterson BA, Hennighausen L, Jensen RA, Merino MJ, Rehm S, Russo J, Tavassoli FA, Ward JM, Wakefield LM and Green JE. (2000) Oncogene, 19, 968-988.
5. Cato AC, Weinmann J, Mink S, Henderson D and Sonnenberg A. (1989). J. Steroid Biochem., 34, 139-143.
6. Choi YW, Lee IC and Ross SR. (1988). Mol. Cell. Biol., 8, 3382-3390.
7. Claessens F, Rushmere NK, Davies P, Celis L, Peeters B and Rombauts WA. (1990). Mol. Cell. Endocrinol., 74, 203-212.
8. Cole CH. (1998). Fields Virology, Vol. 2. Fiels BN., Knipe DM and Howley, PM. (eds). Lippincott-Raven: Philadelphia, pp 1997-2076.
9. Cox LA, Chen G and Lee EY. (1994). Breast Cancer Res. Treat., 32, 19-38.
10. Dyson N, Buchkovich K, Whyte P and Harlow E. (1989). Cell, 58, 249-255.
11. Furth PA. (1998). Dev. Biol. Stand., 94, 281-287.
12. Heyns W and DeMoor P. (1977). Eur. J. Biochem., 15, 221-230.
13. Hodi FS and Dranoff G. (1998). Surg. Oncol. Clin. N. Am., 7, 471-485.
14. Hurwitz AA, Yu TF, Leach DR and Allison JP. (1998). Proc. Natl. Acad. Sci. USA, 95, 10067-10071.
15. Liu M, Von Lintig F, Liyanage M, Shibata M, Jorcyk C, Ried T, Boss G and Green J. (1998). Oncogene, 17, 2403-2411.
16. Macleaod KF and Jacks T. (1999). J. Pathol., 187, 43-60.
17. Maroulakou IG, Anver M, Garrett L and Green JE. (1994). Proc. Natl. Acad. Sci., USA, 91, 11236-11240.
18. Maroulakou IG, Shibata M-A, Anver M, Jorcyk CL, Liu M-L, Roche N, Roberts A, Tsarfaty I, Reseau J, Ward J and Green JE. (1999). Oncogene, in press.
19. Maroulakou IG, Shibata M-A, Jorcyk CL, Chen X-X and Green JE. (1997). Mol. Carcinogen., 20, 168-174.
20. Martini F, Lazzarin L, Iaccheri L, Corallini A, Berosa M, Trabenaclli C, Calza N, Barbanti-Brodana G and Tongnon M. (1998). Dev. Biol. Stand., 94, 55-56.
21. Merlino G. (1994). Semin. Cancer Biol., 5, 13-20.
22. Mietz JA, Unger T, Huibregtse JM and Howley PM. (1992). EMBO, J., 11, 5013-5020.
23. Moens U, Seternes OM, Johansen B and Rekvig OP. (1997). Virus Genes, 15, 135-154.
24. Parker MG, Webb P, Needham M, White R and Ham J. (1987). J. Cell. Biochem., 35, 285-292.
25. Pittius CW, Sankaran L, Topper YJ and Hennighausen L. (1988). Mol. Endocrinol., 2, 1027-1032.
26. Rushmere NK, Parker MG and Davies P. (1987). Mol. Cell. Endocrinol., 51, 259-265.
27. Shibata M-A, Jorcyk CJ, Devor DE, Yoshidome K, Rulong S, Resau J, Roche N, Roberts AB, Ward JM and Green JE. (1998a). Carcinogenesis, 19, 195-205.
28. Shibata M-A, Jorcyk CL, Liu M-L, Yoshidome K, Gold GL and Green JE. (1998b). Toxicol. Pathol., 26, 177-182.
29. Shibata M-A, Liu M-L, Knudson MC, Shibata E, Yoshidome K, Bandey T, Korsmeyer SJ and Green JE. (1999). EMBO J, 18, 2692-2701.
30. Shibata M-A, Maroulakou IG, Jorcyk CL, Gold LG, Ward JM and Green JE. (1996a). Cancer Res., 56, 2998-3003.
31. Shibata M-A, Ward JM, Devor DE, Liu M-L and Green JE. (1996b). Cancer Res., 56, 4894-4903.
32. Stamp G, Poulson R, Jamieson S, Smith R, Pertsers G and Dickson C. (1992). Cell Growth, Differ., 3, 929-938.
33. Tan J, Marschke KB, Ho K-C, Perry ST, Wilson EM and French FS. (1992). J. Biol. Chem., 267, 4456-4466.
34. Tehranian A, Morris DW, Min BH, Bird DJ, Cardiff RD and Barry PA. (1996). Am. J. Pathol., 149, 1177-1191.
35. Vanaken H, Claessens F, Vercaeren I, Heyns W, Peeters B and Rombauts W. (1996). Mol. Cell. Endocrinol., 121, 1967-2205.
36. Voest EE, Kenyon BM, O'Reilly MS, Truitt G, D'Amato RJ and Folkman J. (1995). J. Natl. Cancer Inst., 81, 581-586.
37. Watson M and Fleming T. (1996). Cancer Res., 56, 860-865.
38. Yin C, Knudson CH, Korsmeyer SJ and Dyke TV. (1997). Nature, 385, 637-640.
39. Zhang X, Chen MW, Ng A, Ng PY, Lee C, Rubin M, Olsson CA and Buttyan R. (1997). Prostate, 32, 16-26.